Literature DB >> 7348762

Anti-HBc of IgM-class, HBeAg and anti-HBe in acute and chronic hepatitis B.

J Aldershvile, M Roggendorf, P Kryger, U Tage-Jensen, F Deinhardt, G G Frösner, F Hardt, J O Nielsen.   

Abstract

The presence and persistence of IgM antibody against hepatitis B core antigen (anti-HBc IgM) and the correlation with other HBV markers were studied in 42 patients, all of whom had acute HBsAg-positive hepatitis but whose subsequent diseases differed. All patients initially had anti-HBc IgM. In 13 out of 15 patients with uncomplicated acute hepatitis, anti-HBc IgM disappeared within 6 months after onset of the disease. In five out of 12 patients, who in spite of transient HBsAg developed chronic liver disease, the anti-HBc IgM persisted for more than 2 years. Among 15 patients with persistent HBsAg, anti-HBc IgM was present from 7 months to more than 8 years. Seroconversion from HBeAg to anti-HBe was observed in seven patients and in five of these anti-HBc IgM disappeared during the follow-up period. These results indicate that anti-HBc IgM can be used as a serological marker of recent or ongoing HBV infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7348762     DOI: 10.1111/j.1600-0676.1981.tb00045.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  A comprehensive approach to male homosexual disorders.

Authors:  E Domovitch
Journal:  Can Fam Physician       Date:  1985-10       Impact factor: 3.275

2.  Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.

Authors:  H F Eggink; H J Houthoff; S Huitema; G Wolters; S Poppema; C H Gips
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

3.  Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections.

Authors:  W H Gerlich; A Uy; F Lambrecht; R Thomssen
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.